Overview of advances in the use of biological proteins in human cancer.
Gutterman
J
J
Department of Clinical Immunology and Biological Therapy, University of Texas System Cancer Center M.D. Anderson Hospital and Tumor Institute, Houston 77030.
D000818:Animals; D001685:Biological Factors / Q000627:therapeutic use*; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D001685:Biological Factors; D006133:Growth Substances; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons